David Ricks, Eli Lilly CEO (David Paul Morris/Bloomberg via Getty Images)
Eli Lilly plans to make tirzepatide next big thing as pharma experiences 'unprecedented' demand for the drug
Eli Lilly has been pushing forward on its plans to expand tirzepatide into a megablockbuster, and while the Big Pharma is touting an increase in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
